We are live on ! Find out more
BRA

Bender Robert & Associates Portfolio holdings

AUM $417M
1-Year Est. Return 25.02%
This Fund
S&P 500
This Quarter Est. Return
-3.65%
1 Year Est. Return
+25.02%
3 Year Est. Return
+98.12%
5 Year Est. Return
+139.29%
10 Year Est. Return
+812.75%
AUM
$342M
AUM Growth
-$19.9M
Cap. Flow
-$3.24M
Cap. Flow %
-0.95%
Top 10 Hldgs %
70.91%
Holding
50
New
–
Increased
8
Reduced
30
Closed
2

Top Buys

Rank Stock Value
1
PANW icon
Palo Alto Networks
PANW
+$175K
2
MSFT icon
Microsoft
MSFT
+$117K
3
FIVE icon
Five Below
FIVE
+$116K
4
DIS icon
Walt Disney
DIS
+$95.1K
5
AMD icon
Advanced Micro Devices
AMD
+$60K

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$797K
2
ISRG icon
Intuitive Surgical
ISRG
+$315K
3
TGT icon
Target
TGT
+$212K
4
PFE icon
Pfizer
PFE
+$208K
5
DUK icon
Duke Energy
DUK
+$206K

Sector Composition

Rank Sector Weight
1 Technology 42.42%
2 Consumer Discretionary 26.33%
3 Healthcare 18.9%
4 Communication Services 10.6%
5 Utilities 0.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABBV icon
26
AbbVie
ABBV
$454B
$1.92M 0.56%
12,884
-731
-5% -$107K
PANW icon
27
Palo Alto Networks
PANW
$259B
$1.64M 0.48%
13,964
+1,480
+12% +$175K
BMY icon
28
Bristol-Myers Squibb
BMY
$128B
$1.61M 0.47%
27,697
-600
-2% -$36.8K
COST icon
29
Costco
COST
$422B
$978K 0.29%
1,731
-60
-3% -$33.1K
JNJ icon
30
Johnson & Johnson
JNJ
$641B
$732K 0.21%
4,701
-408
-8% -$67.3K
MRK icon
31
Merck
MRK
$323B
$717K 0.21%
6,966
-550
-7% -$59.3K
ABT icon
32
Abbott
ABT
$182B
$709K 0.21%
7,316
-825
-10% -$86.6K
PAYX icon
33
Paychex
PAYX
$41.1B
$623K 0.18%
5,405
-300
-5% -$36.2K
JPM icon
34
JPMorgan Chase
JPM
$947B
$517K 0.15%
3,566
– –
BA icon
35
Boeing
BA
$167B
$510K 0.15%
2,659
-30
-1% -$6.56K
DE icon
36
Deere & Co
DE
$169B
$506K 0.15%
1,340
-16
-1% -$6.6K
NUE icon
37
Nucor
NUE
$56.4B
$503K 0.15%
3,220
-40
-1% -$6.62K
URGN icon
38
UroGen Pharma
URGN
$2.02B
$486K 0.14%
34,701
– –
BCRX icon
39
BioCryst Pharmaceuticals
BCRX
$2.43B
$401K 0.12%
56,600
-12,000
-17% -$86.2K
CAT icon
40
Caterpillar
CAT
$402B
$388K 0.11%
1,422
– –
PFE icon
41
Pfizer
PFE
$141B
$276K 0.08%
8,310
-5,875
-41% -$208K
V icon
42
Visa
V
$689B
$258K 0.08%
1,120
– –
ORCL icon
43
Oracle
ORCL
$345B
$253K 0.07%
2,389
– –
EOLS icon
44
Evolus
EOLS
$407M
$229K 0.07%
25,070
– –
IDXX icon
45
Idexx Laboratories
IDXX
$43.9B
$201K 0.06%
460
– –
SMMT icon
46
Summit Therapeutics
SMMT
$10.5B
$45K 0.01%
24,059
– –
PLSE icon
47
Pulse Biosciences
PLSE
$2.27B
$41.6K 0.01%
10,325
– –
CMRX
48
DELISTED
Chimerix, Inc.
CMRX
$10.2K ﹤0.01%
10,609
– –
DUK icon
49
Duke Energy
DUK
$100B
– –
-2,290
Closed -$206K
TGT icon
50
Target
TGT
$63.7B
– –
-1,605
Closed -$212K
1
2

Similar funds

AWCI
Alpine Woods Capital Investors Purchase, New York $417M AUM 26.83% 1-Year Est. Return
ACM
Alight Capital Management New York $417M AUM 98.18% 1-Year Est. Return
PA
PSI Advisors Tampa, Florida $418M AUM 15.55% 1-Year Est. Return
CEI
Clark Estates Inc New York $416M AUM 6.04% 1-Year Est. Return
MCM
Millstreet Capital Management Boston, Massachusetts $418M AUM 80.77% 1-Year Est. Return
SSC
Spruce Street Capital New York $416M AUM
SCP
Stevens Capital Partners Omaha, Nebraska $416M AUM 18.93% 1-Year Est. Return
VM
Venator Management Pittsburgh, Pennsylvania $416M AUM 16.01% 1-Year Est. Return

Bender Robert & Associates's Q3 2023 Portfolio in Review

As of Q3 2023, Bender Robert & Associates held 50 positions worth $342M, down 5.5% from $362M the previous quarter. Its ten largest holdings account for 71% of the portfolio.

Trading was light in Q3 2023: portfolio turnover was 4%. Bender Robert & Associates opened no new positions and exited 2, leaving the 50-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 42% of assets, down from 43% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Bender Robert & Associates added most to Palo Alto Networks in Q3 2023, an estimated $175K increase.
  • Bender Robert & Associates's biggest Q3 2023 reduction was Apple, cutting an estimated $797K.
  • Bender Robert & Associates fully exited Target in Q3 2023, selling an estimated $212K.
  • Bender Robert & Associates's ten largest holdings make up 71% of its $342M portfolio in Q3 2023.
  • Bender Robert & Associates opened 0 new positions and closed 2 in Q3 2023.
  • Bender Robert & Associates's portfolio value fell 5.5% quarter-over-quarter to $342M.

Based on Bender Robert & Associates's 13F filing for Q3 2023, filed 16 Oct 2023.